Clinical Trial Imaging Market to be Valued $1.31 Billion by 2026 : Grand View Research, Inc

Clinical Trial Imaging Market to be Valued $1.31 Billion by 2026 : Grand View Research, Inc

“Grand View Research, Inc. – Market Research And Consulting”
According to report published by Grand View Research, Growing pharmaceutical and biotechnology companies coupled with increasing investments in the field of R&D for developing new drugs to cure diseases is one of the key trends escalating clinical trial imaging market growth

The global Clinical Trial Imaging Market size is expected to reach USD 1.31 billion by 2026, according to a new report by Grand View Research, Inc., progressing at a CAGR of 5.8% during the forecast period. Increasing spending on research and development activities to develop new drugs and therapies to treat chronic diseases is boosting market growth.

Clinical trials assist in the development, registration, and eventually access of new drugs to patients. Imaging helps in the process of drug development by offering non-invasive evaluation of drug action and response of tumor to treatment. Functional imaging techniques are progressively being used in early phases of clinical trials to study initial effects of drug action on parts of tumor biology including metabolism, cellularity, and vascularity. 

Contract Research Organizations (CROs) were the most prominent end-use segment in the market in 2017. Imaging modalities are used to determine indicators of pharmacological response to a therapy. Biomarkers and surrogate endpoints assist in obtaining quick results with good statistical power even in small sample sizes encouraging CROs to carryout multiple studies with reduced cost of operation.

The market in Asia Pacific is projected to witness swift growth during the forecast period as the number of CROs and pharmaceutical organizations in the region are increasing in recent past due to low cost of labor and public and private funding offered in countries such as India and China. However, inaccessibility of trial protocols and poor quality of registered clinical trial data, results, and participant-level data undermined the potential benefits of clinical trial registration earlier. Nevertheless, emergence of national and regional registries and ICTRP have facilitated to overcome aforementioned barriers in APAC.

U.S. clinical trial imaging market size, by service, 2014 - 2026 (USD Million)


Request a sample Copy of the Global Clinical Trial Imaging Market Research Report @
https://www.grandviewresearch.com/industry-analysis/clinical-trial-imaging-market/request/rs1

Further key findings from the report suggest

  • North America dominated the market in 2017. Attaining compliance with registration requires a combination of international and local measures and remains a key challenge in many countries. However, U.S. FDA and other regulatory organizations have played a leading role in attaining accomplishments of trial registration to date and is likely to be supported in tackling such challenges in the near future
  • Some of the players operating in this market are Parexel International Corporation; Intrinsic Imaging; Radiant Sage; Icon PLC; Worldcare Clinical; Bioclinica Inc.; Navitas Life Sciences; Resonance Health; Ixico PLC; and Medpace.

Global clinical trial imaging market share, by end-use, 2017 (%) 


Have Any Query? Ask Our Experts @
https://www.grandviewresearch.com/inquiry/5483/ibb

Grand View Research has segmented the global clinical trial imaging market based on service, modalities, end-use, and region:

Clinical Trial Imaging Service Outlook (Revenue, USD Million, 2014 – 2026)   

  • Clinical trial design and consultation services
  • Reading and analytical Services
  • Operational Imaging services
  • System and technology support services
  • Project and Data Management

Clinical Trial Imaging Modalities Outlook (Revenue, USD Million, 2014 – 2026)          

  • Computed Tomography (CT) Scan
  • MRI ( Magnetic Resonance Imaging)
  • X-Ray
  • Ultrasound
  • Optical Coherence Tomography (OCT)
  • Others (Positron Emission Tomography (PET), Single-Photon Emission Computerized Tomography (SPECT)Reading and analytical Services

Clinical Trial Imaging End-use Outlook (Revenue, USD Million, 2014 – 2026)

  • Biotechnology and Pharmaceutical companies
  • Medical Devices Manufacturers
  • Academic and government research institutes
  • Contract Research Organization (CROs)
  • Others (Cosmetics and skin care industries)

Clinical Trial Imaging Regional Outlook (Revenue, USD Million, 2014 – 2026)

  • North America
    • U.S.
    • Canada
  • Europe
    • U.K.
    • Germany
  • Asia Pacific
    • India
    • China
  • Latin America
    • Brazil
    • Mexico
  • Middle East & Africa
    • South Africa
    • Saudi Arabia

Browse Related Category @

Electrophysiology Devices Market – https://www.grandviewresearch.com/industry-analysis/electrophysiology-devices-market

Neurology Devices Market – https://www.grandviewresearch.com/industry-analysis/neurology-devices-market

About Grand View Research

Grand View Research provides syndicated as well as customized research reports and consulting services on 46 industries across 25 major countries worldwide. This U.S.-based market research and consulting company is registered in California and headquartered in San Francisco. Comprising over 425 analysts and consultants, the company adds 1200+ market research reports to its extensive database each year. Supported by an interactive market intelligence platform, the team at Grand View Research guides Fortune 500 companies and prominent academic institutes in comprehending the global and regional business environment and carefully identifying future opportunities.

Media Contact
Company Name: Grand View Research, Inc.
Contact Person: Sherry James, Corporate Sales Specialist – U.S.A.
Email: Send Email
Phone: 1-415-349-0058, Toll Free: 1-888-202-9519
Address:201, Spear Street, 1100
City: San Francisco
State: California
Country: United States
Website: www.grandviewresearch.com/industry-analysis/clinical-trial-imaging-market